首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   49847篇
  免费   2643篇
  国内免费   1933篇
耳鼻咽喉   102篇
儿科学   252篇
妇产科学   363篇
基础医学   1409篇
口腔科学   354篇
临床医学   6074篇
内科学   3860篇
皮肤病学   333篇
神经病学   491篇
特种医学   1060篇
外国民族医学   21篇
外科学   2060篇
综合类   13315篇
预防医学   4799篇
眼科学   214篇
药学   11559篇
  129篇
中国医学   6881篇
肿瘤学   1147篇
  2024年   474篇
  2023年   1568篇
  2022年   1845篇
  2021年   2414篇
  2020年   1659篇
  2019年   1535篇
  2018年   812篇
  2017年   1377篇
  2016年   1376篇
  2015年   1705篇
  2014年   2415篇
  2013年   2442篇
  2012年   3044篇
  2011年   3033篇
  2010年   2850篇
  2009年   2854篇
  2008年   3270篇
  2007年   2689篇
  2006年   2478篇
  2005年   2409篇
  2004年   1808篇
  2003年   1723篇
  2002年   1363篇
  2001年   1222篇
  2000年   924篇
  1999年   742篇
  1998年   629篇
  1997年   579篇
  1996年   541篇
  1995年   502篇
  1994年   422篇
  1993年   310篇
  1992年   275篇
  1991年   266篇
  1990年   207篇
  1989年   213篇
  1988年   111篇
  1987年   116篇
  1986年   84篇
  1985年   58篇
  1984年   31篇
  1983年   26篇
  1982年   18篇
  1981年   1篇
  1980年   1篇
  1958年   1篇
  1955年   1篇
排序方式: 共有10000条查询结果,搜索用时 13 毫秒
81.
1临床资料 本组39例中,男28例,女11例;年龄最小28岁,最大66岁;病程最短5d,最长3a。 2治疗方法 2.1药物组成川乌500g,草乌500g,青风藤500g,乳香500g,没药500g。  相似文献   
82.
Clavis制药公司在晚期急性髓系白血病患者中进行二期临床试验,他们宣布艾西拉滨(CP-4055)第二次中期分析结果阳性。独立的数据监察委员会对来自加个患者的临时数据分析进行评估,审查报告确认了首次由20个患者得出的阳性结果。做为二期临床试验的一部分,晚期髓系白血病患者(难治疗组)接受了三线治疗,也称为第二次抢救治疗。因为没有一个标准疗法,  相似文献   
83.
84.
二甲双胍对老年2型糖尿病患者的疗效及安全性   总被引:1,自引:1,他引:0  
目的:观察二甲双胍对老年2型糖尿病患者的疗效与安全性。方法:42例老年2型糖尿病患者服用磺脲类降糖药物效果不佳时加服二甲双胍治疗,在随访24周的过程中,监测空腹血糖、糖化血红蛋白、胰岛素、血乳酸及血脂,并观察药物的副作用。结果:治疗后4周空腹血糖(7.6±1.9)mmol/Lvs(9.8±2.2)mmol/L,P<0.01、糖化血红蛋白(11.3±2.6)%vs(13.6±2.5)%,P<0.01显著下降;服药12周后LDL(2.3±0.8)mmol/Lvs(2.8±0.9)mmol/L,P<0.01、TG(3.0±1.1)mmol/Lvs(3.6±1.2)mmol/L,P<0.01显著下降;服药24周HDL升高(0.89±0.08)mmol/Lvs(0.85±0.08)mmol/L,P<0.01,但血胰岛素(16.7±3.6)mmol/Lvs(18.2±4.1)mmol/L,P>0.05、血乳酸(1.6±0.5)mmol/Lvs(1.4±0.5)mmol/L,P>0.05无显著变化。23.8%患者服用二甲双胍后出现恶心与腹泻,但症状轻微且短暂。结论:二甲双胍是治疗老年2型糖尿病患者安全、有效的药物。  相似文献   
85.
碳水化合物减肥法的速效瘦身功效已经受到了很多MM的肯定,但也有些读者反映用此方法后容易反弹。怎样才能找到一条既快速燃脂又不复胖的瘦身之路,就让《瘦佳人》告诉你!  相似文献   
86.
87.
BACKGROUND: During formation of prolactin neoplasia, how cells and its structure in adenohypophysis affect prolactin cells should be further studied. Intermediate lobe can be regarded as a driving region to release prolactin (PRL) and may promote formation of prolactin neoplasia in pituitary anterior lobe. OBJECTIVE: To observe the effect of diethylstilbestrol (DES) on the expressions of μ and m-calpains in pituitary intermediate lobe of female Wistar rats. DESIGN: Observational contrast animal study. SETTING: Beijing Neurosurgical Institute. MATERIALS: A total of 21 female Wistar rats, 3 weeks old weighing 70–80 g were housed with free access to tap water and standard pellet food. They were kept in a CL-grade condition, at (24±1)℃ and a humidity of (55±5)%, and with a 12 hours day-night cycle. Caprine anti-μ- and m-calpains antibodies were provided by Santa Cruz Biotechnology, CA, USA; rabbit-anti-PRL antibodies by Dako, Denmark; rabbit-anti-ACTH antibody by Boster Company, Wuhan. METHODS: The experiment was carried out in Pathophysiological Department and Animal Laboratory, Beijing Neurosurgical Institute from August 2006 to January 2007. ① Rats were randomly divided into groups with 7 in each group, including vehicle control group, in which rats were injected intraperitoneally with sun-flower seed oil (1 mL/kg, twice a week) for 16 weeks; DES group, where animals were administered with DES (5 mg/kg, twice a week) for 16 weeks; DES + vehicle control group, in which DES was administered for 12 weeks at the same dose with those in DES group, and then was discontinued and replaced by sun-flower seed oil (1 mL/kg, twice a week) for the following 4 weeks. ② At 16 weeks later, pituitary tissue was dealt with HE staining and PRL immunohistochemical examination to observe evoke of tumor; meanwhile, immunohistochemical examination was used to observe expression of PRL of pituitary anterior lobe, expressions of μ- and m-calpains of pituitary intermediate lobe and distribution of adrenocorticotropin. MAIN OUTCOME MEASURES: ① Expression of PRL of pituitary anterior lobe, expressions of μ- and m-calpains of pituitary intermediate lobe and distribution of adrenocorticotropin. ② Morphological observation of pituitary tissue. RESULTS: All 21 rats were involved in the final analysis. ① Results of immunohistochemical examination: Morphological changes of neoplasia in DES group were strongly positive to PRL, and this suggested that formation of prolactin adenoma was observed in pituitary tissue. As compared with vehicle control group, expression of adrenoeorticotropic hormone (ACTH) was increased in both DES group and DES + vehicle control group. In addition, expressions of μ- and m-calpains in pituitary intermediate lobe were higher in DES group than that in vehicle control group. Otherwise, expressions of m-calpains in pituitary intermediate lobe was decreased in DES + vehicle control group, but expression of μ-calpains was still increased. ② Morphological observation of pituitary tissue: Gland tubes were orderly arranged in rats in vehicle control group. Anterior pituitary gland in rats of DES group demonstrated an apparent disappearance of gland tubes and a relatively large-scaled vasculature formation, namely the vascular lake lined by tightly arranged endothelial cells. Local integrated tumor cell arrangements were also detected. In addition, the border between the IL and the anterior lobe was locally blurred. The definite tumor-like changes in pituitary tissues were confirmed in 6 of 7 female Wistar rats in DES group, and one spontaneous occurrence of tumor formation was found in vehicle control group. In DES + vehicle control group, DES withdrawal led to the subtile emergence of gland tube cavity, although tumor-like cells still existed in 4 of 7 rats, suggesting occurrence of the tumor regression due to the withdrawal of DES. CONCLUSION: A long-term application of DES can enhance the expressions of ubiquitours neutral cysteine protease in pituitary intermediate lobe and this suggests that both of them play a key role in release of hormone and formation of prolactin neoplasia through directly promoting PRL expression and release of neighboring pituitary intermediate lobe.  相似文献   
88.
糖耐量减低是正常糖代谢与糖尿病之间的中间代谢状态,是发展为糖尿病和心血管疾病的重要危险因素之一[1,2]。因此,积极干预治疗糖耐量减低对于预防糖尿病和心血管疾病的发生具有十分重要的意义。  相似文献   
89.
目的 对二甲双胍的应用提供临床依据.方法 查阅国内外近几年的研究和相关文献资料.结果 二甲双胍能减少IGT患者糖尿病的发生率,明显降低T2DM的血糖,并因不良反应少,而使患者有良好的依从性.结论 早期应用二甲双胍治疗是必要和可行的措施.  相似文献   
90.
小柴胡汤加减治疗消化性溃疡80例   总被引:1,自引:0,他引:1  
自2003年3月~2006年3月,笔者应用小柴胡汤加减治疗消化性溃疡患者80例,临床上取得满意的疗效,现报告如下。1临床资料1.1一般资料本组80例病例经电子胃镜检查确诊为消化性溃疡并同时行幽门螺旋杆菌(Hp)培养为阳性。80例中男45例,女35例;年龄22岁~60岁.其中,30~50岁占总数的70%;病程0.5~1a。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号